ESSENTIAL REQUIREMENTS:

• Consolidated PhD in Neuroscience, Molecular Biology, Biomedicine, or a closely related field, with a track record of relevant publications.
• Demonstrable and deep experience in cell and molecular biology applied to neurodegenerative disease models, with a particular focus on ALS.
• Evidence of laboratory experience with Drosophila melanogaster in neurodegenerative diseases.
• Functional and molecular biology assays experience, including the generation and characterization of double and triple transgenic models.
• Advanced experience in handling complex animal models (preferably Drosophila melanogaster) and culturing human neuronal cells (including iPSCs or primary models).
• Experience in pharmacological and genetic modification of Drosophila strains.
• Expert knowledge of advanced imaging techniques, such as confocal microscopy, fluorescence, and/or super-resolution microscopy, with the ability to perform quantitative image analysis.
• Exceptional skills in analyzing experimental data, with proficiency in statistical and computational analysis tools (Python, R, MATLAB, etc.).
• Experience in cell metabolism studies.
• Excellent command of written and spoken English, with a proven track record of writing and publishing scientific papers in high-impact journals.
• Strong strategic interest and motivation for translational research and therapeutic validation in the field of neurodegenerative diseases, specifically ALS.
• Proven ability to work independently and as part of a high-performance multidisciplinary team.

WILL BE CONSIDERED A PLUS:

• Experience in bioinformatics applied to omics data (genomics, transcriptomics).
  • Knowledge in the design and management of drug screening or therapeutic assays.
  • Experience in project funding (grant application and management).
  • Strong communication and presentation skills in international scientific environments.
• Possession of a disability certificate of 33% or higher.

• TYPE OF CONTRACT: 36-month Postdoctoral Access contract with the possibility of an extension.
• TIPE OF WORKDAY: Full-time
• EXPECTED START DATE: July 2025
• ANNUAL GROSS SALARY: 29.000€ - 32.000€ gross per year.

The remuneration will be assigned based on the candidate's dedication, merit, and suitability for the offered position. The employee must adhere to the internal rules and regulations of the Biogipuzkoa Institute regarding dedication, the role to be performed, working hours, leave, etc.

Applications meeting the REQUIRED competencies in the job posting will be evaluated.

• EXPERIENCE (0-30 PTS)
• KNOWLEDGE (ACCREDITED) (0-20 PTS)
• LANGUAGES (ENGLISH) (0-20 PTS)
• OTHER MERITS (0-20 PTS)
• CERTIFICATE OF DISABILITY MINIMUM 33% (0-10 PTS)
• INTERVIEW (0-25 PTS)

APPLICATION FORMALIZATION

It is mandatory to apply for the position through the job portal on the IIS Biogipuzkoa website (www.biodonostia.org). No paper documentation will be accepted. All documents must be submitted electronically via this website.

BIOGIPUZKOA is committed to the principles of merit-based recruitment and transparency (OTM-R Policy), in accordance with the requirements of the HRS4R Seal established by the European Commission. Additionally, it has taken on the responsibility of ensuring gender equality through actions outlined in the current Equality Plan.

After the evaluation and selection process, candidates may request information about their scores, as well as the score of the selected candidate.

For any questions or clarifications, please contact via email at rrhh@bio-gipuzkoa.eus 

Deadline for CV submission: 07/24/2025